Photo of David N. ParsigianPhoto of David N. Parsigian

David N. Parsigian

Partner
Leader, Venture Capital Practice Group
Office Managing Partner, Ann Arbor

Education

University of Texas at Austin School of Law, J.D.
  • with honors
University of Michigan, B.S.M.E.
  • Mechanical Engineering
  • magna cum laude; Tau Beta Pi (National Engineering Honor Society)

Prior Employment

  • Miller, Canfield, Paddock and Stone, P.L.C., Senior Partner, 1993-2006; Associate, 1984-1992 (Deputy Leader, Corporate and Securities and Leader, High-technology Ventures Group)
  • Exxon Chemical Company, Engineer, 1980-1982

Bar Admissions

Professional Affiliations

American Bar Association

  • Negotiated Acquisitions and Venture Capital and Private Equity Committees

State Bar of Michigan

Overview
Experience
Community
News & Resources
Honors

Overview

David Parsigian is a nationally known venture capital and mergers and acquisitions lawyer with deep capabilities and broad experience in corporate, securities, and finance law. He places particular emphasis on representation of emerging technology companies and their funding sources from inception through acquisition or initial public offering, venture capital finance, private placements, joint ventures, technology licensing, strategic alliances, and mergers and acquisitions. 

  • Represents high-technology companies in information technology, biotechnology and life sciences, medical devices, and advanced manufacturing industries
  • Represents corporations and institutional venture and private equity firms in their high-technology and growth-equity investment activities
  • Serves as managing partner of the firm’s Ann Arbor office and as a member of the firm's Board of Directors
  • Representative Venture Fund Clients: 
    • Arboretum Ventures 
    • DTE Energy Ventures 
    • General Motors Ventures
    • Plymouth Venture Partners
    • Renaissance Venture Capital Fund 
    • Detroit Innovate Fund
    • Venture Michigan Fund 

Experience

Venture Financing Transactions

David has been the lead counsel for over $3 billion in venture- and growth-stage equity and debt financings, representing companies and investors across a wide range of industries. He is particularly accomplished in representing strategic investors in making minority investments and in structuring the commercial arrangements that often accompany these types of investments.

  • Served as lead counsel for institutional investors and as company counsel for more than 100 venture financings, ranging from Series A to Series E for companies in the areas of:
    • autonomous vehicles and related technologies
    • information technology
    • advanced manufacturing and materials
    • medical devices
    • drug therapies
    • healthcare delivery
  • Represented Venture Michigan Fund in its $200 and $250 million structured debt financings 
Mergers and Acquisitions
  • Served as lead counsel in more than 30 dispositions of technology-based and other companies on both the buy and sell sides
    • Adaptive Materials, Inc. (in its sale to Ultra Electronics) 
    • Afmedica, Inc. (in its sale to Angiotech Pharmaceuticals, Inc.) 
    • Altarum Institute (in its sale of NewVectors Holdings and its acquisitions of KAI Research, Inc. and Palladian Partners) 
    • American International Airways, Inc. (in its sale to Kitty Hawk, Inc.) 
    • Applimation, Inc. (in its acquisitions of Tickmark Solutions, Inc. and Gamma Enterprise Technologies and in its $40 million sale to Informatica, Inc.) 
    • Cielo MedSolutions, LLC (in its sale to The Advisory Board) 
    • ForeSee Results, Inc. (in its sale to Answers Corporation)
    • MedHub, Inc. (in its sale to Ascend Learning)
    • Merchant Internet Group, Inc. (in its sale to Netlink Corporation) 
    • NSF International (in its acquisitions of Quality Assurance International, Davis Fresh Technologies, Surefish, Pharmalytica Services, and Becker Venture Services Group) 
    • Neural Intervention Technologies, Inc. (in its sale to W.L. Gore & Associates) 
    • NeuroNexus Technologies, Inc. (in its sale to Greatbatch, Inc.)
    • Optiant, Inc. (in its sale to WebMD, Inc.) 
    • Rubicon Genomics, Inc. (in its sale to Takara Bio)
    • Picometrix, Inc. (in its sale to Advanced Photonix, Inc.) 
    • T/J Technologies, Inc. (in its sale to A123 Systems, Inc.) 
    • Xoran Technologies, Inc. (in the sale of its dental division)
Fund Formation

David is one of the few lawyers in Michigan who has the proficiency and market understanding to form and maintain venture capital and growth equity funds. 

Community

Ann Arbor SPARK (the economic development organization focused on establishing the Ann Arbor region as a destination for business expansion, retention and relocation)

  • Board Vice Chair
  • Executive Committee Member

University Musical Society

  • Former Treasurer
  • Board Member

Arbor Area Chamber of Commerce

  • Former Chairman of the Board, 2006

Great Lakes Entrepreneurs Quest (a business plan competition for the State of Michigan)

  • Founder
  • Former Executive Committee Member

Nonprofit Enterprise at Work (business support for nonprofit organizations)

  • Former Board Member

Washtenaw Community College Foundation

  • Former Chair, 2002-2004

News & Resources

News

Press Releases

Seminars & Events

Honors

  • Listed in Chambers USA: America's Leading Lawyers for Business since 2006
    • Recognized as one of America's leading business lawyers in the Corporate/M&A field; Chambers USA states: 
      • 2017 – "[David] has wide-ranging expertise in matters of corporate, financial and securities law. Sources highlight his strong track record in representing technology investors in acquisitions, IPOs and joint ventures. Commentators also describe him as a 'very practical lawyer' who is 'knowledgeable' and 'represents clients well.'"
      • 2016 – "David Parsigian is highly commended by sources for his strategic and practical approach to cases. His practice encompasses a broad range of corporate matters, including public offerings, joint ventures and M&A transactions."
      • 2015 – "The 'very talented' and 'incredibly smart' David Parsigian is a noted expert in venture capital work and enjoys a fine track record acting on behalf of emerging technology companies."
      • 2014 – "[David] is praised for his experience and attention to detail, particularly in the field of venture capital. His practice has a particular emphasis on representing emerging technologies companies with transactional matters."
      • 2013 – "Clients report that 'he is great to work with and very diligent.'"
      • 2012 – "David Parsigian is a highly respected attorney who is noted for his expertise in private equity and venture capital matters. He is particularly active in the IT and life sciences industries."
  • Michigan Economic Development Corporation, Michigan Investment and Commercialization Success Award
  • The Best Lawyers in America, 2007-2017
    • Named Ann Arbor Mergers & Acquisitions Lawyer of the Year, 2013 and 2016
  • Leading Lawyers Magazine Michigan, 2017
    • Recognized in practice areas of:
      • Biotechnology Law
      • Mergers & Acquisitions Law
      • Publicly Held Corporations Law
      • Securities & Venture Finance Law
  • DBusiness, Top Lawyers, 2013-2015
  • Michigan Venture Capital Association's “Above and Beyond” Award
    • Two-time recipient
  • Michigan Super Lawyers, 2008-2016
    • Recognized as one of the:
      • Top 50 Business Super Lawyers, 2014 and 2015
      • Top 100 Super Lawyers, 2009 and 2014-2016
  • Martindale-Hubbell AV® Preeminent™ Peer Review Rated

Academic Appointments

  • University of Michigan Law School, Zell Entrepreneurship and Law Program, Adjunct Clinical Assistant Professor
  • University of Michigan Ross School of Business, Venture Capital Finance, Lecturer
  • Michigan State University Broad College of Business, Venture Capital Finance, Lecturer
  • Wayne State University Business School, Venture Capital Finance, Lecturer